U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · IEX Real-Time Price · USD
100.38
-3.27 (-3.15%)
Apr 25, 2024, 4:00 PM EDT - Market closed
U.S. Physical Therapy Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for USPH stock have an average target of 125.67, with a low estimate of 117 and a high estimate of 138. The average target predicts an increase of 25.19% from the current stock price of 100.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 13, 2024.
Analyst Ratings
The average analyst rating for USPH stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Buy Maintains $99 → $117 | Buy | Maintains | $99 → $117 | +16.56% | Mar 13, 2024 |
Barrington Research | Barrington Research | Buy Maintains $120 → $122 | Buy | Maintains | $120 → $122 | +21.54% | Mar 1, 2024 |
Barrington Research | Barrington Research | Buy Maintains $111 → $120 | Buy | Maintains | $111 → $120 | +19.55% | Jan 3, 2024 |
JP Morgan | JP Morgan | Buy Maintains $108 → $99 | Buy | Maintains | $108 → $99 | -1.37% | Nov 17, 2023 |
Barrington Research | Barrington Research | Buy Maintains $124 → $111 | Buy | Maintains | $124 → $111 | +10.58% | Nov 9, 2023 |
Financial Forecast
Revenue This Year
649.80M
from 604.80M
Increased by 7.44%
Revenue Next Year
682.79M
from 649.80M
Increased by 5.08%
EPS This Year
2.83
from 1.28
Increased by 121.13%
EPS Next Year
3.15
from 2.83
Increased by 11.35%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 677.6M | 723.9M | 776.4M |
Avg | 649.8M | 682.8M | 732.1M |
Low | 616.0M | 637.0M | 682.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 12.0% | 11.4% | 13.7% |
Avg | 7.4% | 5.1% | 7.2% |
Low | 1.9% | -2.0% | -0.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | 3.35 | 3.52 | 3.84 |
Avg | 2.83 | 3.15 | 3.55 |
Low | 2.52 | 2.86 | 3.23 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 161.7% | 24.3% | 21.9% |
Avg | 121.1% | 11.4% | 12.6% |
Low | 96.8% | 1.1% | 2.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.